Although not completely elucidated at a mechanistic level, the role of GFI1 in facilitating DNA repair clearly translates into a greater resistance of tumour cells to treatments that are based on induction of DNA damage such as radiation therapy or the use of chemotherapeutic drugs such as Cytarabine or Doxorubicin. The gene discussed is GFI1; the disease is neoplasm.